Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance
Article in Clinical Pharmacokinetics (June 2022)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)‐Warfarin
Article in Clinical Pharmacology & Therapeutics (May 2022)
Polymorphisms of genes related to phase-I metabolic enzymes affecting the clinical efficacy and safety of clopidogrel treatment
Article in Expert Opinion on Drug Metabolism & Toxicology (May 2021)